FutureMeds is an independent, fully-owned European Site Network and DCT service provider dedicated to running patient-centric clinical trials and delivering quality data for the world’s leading Sponsors & CROs. With 24 strategically located sites, over 220 experienced investigators, and more than 1350 homecare providers, FutureMeds offers site and DCT solutions across most therapeutic areas and provides reliability, efficiency and accuracy to help clients accelerate patient access to new treatments. To learn more about how FutureMeds can support your trial, reach out to our team or visit futuremeds.com LinkedIn Privacy Policy: https://www.futuremeds.com/linkedin-privacy-policy